International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
South African Institute of Town and Regional Planners revolution in that country. The institute was perceived by some to harbour apartheid prejudice. The Development Planning Association of South Africa (DPASA) was founded in January 1994 by younger planners who criticised the lack of action on the part of the SAITRP in promoting transformation of both South African society. In 1996 both the South African Institute of Town and Regional Planners and Development Planning Association gave way to the South African Planning Institute. This new institute incorporated within its objectives that showed clear support for the values of post-apartheid South Africa, and the SAITRP was dissolved. South African Institute